StocksMedium•9 October 2026•
1 min read
Moderna Options Surge on Nasdaq-100 Inclusion and Positive Melanoma Data
Key Facts
1Moderna options saw a significant surge in call buying activity as the company joins the Nasdaq-100 index.
2Positive data regarding melanoma treatment contributed to the bullish sentiment surrounding the stock.
Moderna options saw a significant surge in call buying activity as the company joins the Nasdaq-100 index. Investing.com reported that positive data regarding melanoma treatment contributed to the bullish sentiment surrounding the stock, as the company replaces Warner Bros Discovery in the index.
MRNA closed at $197 on October 8, 2026, reaching a session high of $199.92. Meanwhile, NDAQ shares closed at $92.37 on October 8, 2026, amid technical and fundamental momentum driven by the index rebalancing and encouraging clinical results.